Alzheimer's disease protein Aβ1-42 does not disrupt isolated synaptic vesicles

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 5, 2008, Pages 326-334

  Allen, Peter B ^a   Chiu, Daniel T ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer's disease; Amyloid beta; Integrity; Leakage; Synaptic vesicle; Total internal reflection fluorescence

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; DYE; PROTON;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; EXPERIMENT; HYPOTHESIS; MOLECULE; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTON TRANSPORT; RAT; SYNAPSE VESICLE;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; FLUORESCENT DYES; HYDROGEN-ION CONCENTRATION; INTRACELLULAR MEMBRANES; MICE; MICROFLUIDICS; MICROSCOPY, FLUORESCENCE; PEPTIDE FRAGMENTS; PERFUSION; RATS; SYNAPTIC VESICLES; SYNAPTOPHYSIN;

EID: 42749089844     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.02.002     Document Type: Article

References (44)

1. Sudhof T.C. The synaptic vesicle cycle. Ann. Rev. Neurosci. 27 (2004) 509-547
2. Tabb J.S., Kish P.E., Van Dyke R., and Ueda T. Glutamate transport into synaptic vesicles. Roles of membrane potential, pH gradient, and intravesicular pH. J. Biol. Chem. 267 (1992) 15412-15418
3. Lynch B.A., Lambeng N., Nocka K., Kensel-Hammes P., Bajjalieh S.M., Matagne A., and Fuks B. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9861-9866
4. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science (New York, N.Y.) 298 (2002) 789-791
5. Tiraboschi P., Hansen L.A., Thal L.J., and Corey-Bloom J. The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62 (2004) 1984-1989
6. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., Krafft G.A., and Klein W.L. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10417-10422
7. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N.Y. Acad. Sci. 924 (2000) 17-25
8. Small D.H., Mok S.S., and Bornstein J.C. Alzheimer's disease and Abeta toxicity: from top to bottom. Nat. Rev., Neurosci. 2 (2001) 595-598
9. Wang H.Y., Lee D.H., D'Andrea M.R., Peterson P.A., Shank R.P., and Reitz A.B. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J. Biol. Chem. 275 (2000) 5626-5632
10. Dineley K.T., Westerman M., Bui D., Bell K., Ashe K.H., and Sweatt J.D. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21 (2001) 4125-4133
11. Levy R.B., and Aoki C. Alpha7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex. J. Neurosci. 22 (2002) 5001-5015
12. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., and Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8 (2005) 1051-1058
13. Skovronsky D.M., Doms R.W., and Lee V.M. Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J. Cell Biol. 141 (1998) 1031-1039
14. Wirths O., Multhaup G., Czech C., Blanchard V., Moussaoui S., Tremp G., Pradier L., Beyreuther K., and Bayer T.A. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 306 (2001) 116-120
15. Takahashi R.H., Milner T.A., Li F., Nam E.E., Edgar M.A., Yamaguchi H., Beal M.F., Xu H., Greengard P., and Gouras G.K. Intraneuronal Alzheimer A-beta 42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161 (2002) 1869-1879
16. Wirths O., Multhaup G., and Bayer T.A. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide-the first step of a fatal cascade. J. Neurochem. 91 (2004) 513-520
17. Zhang Y., McLaughlin R., Goodyer C., and LeBlanc A. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. J. Cell Biol. 156 (2002) 519-529
18. Soreghan B., Kosmoski J., and Glabe C. Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation. J. Biol. Chem. 269 (1994) 28551-28554
19. Rhee S.K., Quist A.P., and Lal R. Amyloid beta protein-(1-42) forms calcium-permeable, Zn2+-sensitive channel. J. Biol. Chem. 273 (1998) 13379-13382
20. McLaurin J., and Chakrabartty A. Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity. J. Biol. Chem. 271 (1996) 26482-26489
21. Bennett M.K., Calakos N., Kreiner T., and Scheller R.H. Synaptic vesicle membrane proteins interact to form a multimeric complex. J. Cell Biol. 116 (1992) 761-775
22. Takahashi R.H., Almeida C.G., Kearney P.F., Yu F., Lin M.T., Milner T.A., and Gouras G.K. Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J. Neurosci. 24 (2004) 3592-3599
23. Kirvell S.L., Esiri M., and Francis P.T. Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease. J. Neurochem. 98 (2006) 939-950
24. Harper J.D., and Lansbury Jr. P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Ann. Rev. Biochem. 66 (1997) 385-407
25. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., and Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13 (1993) 1676-1687
26. Hell J.W., Maycox P.R., Stadler H., and Jahn R. Uptake of GABA by rat brain synaptic vesicles isolated by a new procedure. EMBO J. 7 (1988) 3023-3029
27. Li Z., Burrone J., Tyler W.J., Hartman K.N., Albeanu D.F., and Murthy V.N. Synaptic vesicle recycling studied in transgenic mice expressing synaptopHluorin. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 6131-6136
28. McDonald J.C., Duffy D.C., Anderson J.R., Chiu D.T., Wu H., Schueller O.J., and Whitesides G.M. Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis 21 (2000) 27-40
29. Simmons L.K., May P.C., Tomaselli K.J., Rydel R.E., Fuson K.S., Brigham E.F., Wright S., Lieberburg I., Becker G.W., Brems D.N., et al. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45 (1994) 373-379
30. Lin H., Zhu Y.J., and Lal R. Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles. Biochemistry 38 (1999) 11189-11196
31. Lorenz R.M., Edgar J.S., Jeffries G.D., and Chiu D.T. Microfluidic and optical systems for the on-demand generation and manipulation of single femtoliter-volume aqueous droplets. Anal. Chem. 78 (2006) 6433-6439
32. Reigada D., Diez-Perez I., Gorostiza P., Verdaguer A., Gomez de Aranda I., Pineda O., Vilarrasa J., Marsal J., Blasi J., Aleu J., and Solsona C. Control of neurotransmitter release by an internal gel matrix in synaptic vesicles. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3485-3490
33. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., and Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6448-6453
34. Stine Jr. W.B., Dahlgren K.N., Krafft G.A., and LaDu M.J. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278 (2003) 11612-11622
35. Ryan T.A., Reuter H., Wendland B., Schweizer F.E., Tsien R.W., and Smith S.J. The kinetics of synaptic vesicle recycling measured at single presynaptic boutons. Neuron 11 (1993) 713-724
36. Sankaranarayanan S., De Angelis D., Rothman J.E., and Ryan T.A. The use of pHluorins for optical measurements of presynaptic activity. Biophys. J. 79 (2000) 2199-2208
37. Kuyper C.L., Kuo J.S., Mutch S.A., and Chiu D.T. Proton permeation into single vesicles occurs via a sequential two-step mechanism and is heterogeneous. J. Am. Chem. Soc. 128 (2006) 3233-3240
38. Kirkitadze M.D., Bitan G., and Teplow D.B. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J. Neurosci. Res. 69 (2002) 567-577
39. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (New York, N.Y.) 297 (2002) 353-356
40. Thomas R.S., Liddell J.E., Murphy L.S., Pache D.M., and Kidd E.J. An antibody to the beta-secretase cleavage site on amyloid-beta-protein precursor inhibits amyloid-beta production. J. Alzheimer's Dis. 10 (2006) 379-390
41. Buckley K., and Kelly R.B. Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. J. Cell Biol. 100 (1985) 1284-1294
42. Yang A.J., Chandswangbhuvana D., Margol L., and Glabe C.G. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J. Neurosci. Res. 52 (1998) 691-698
43. Rodrigues C.M., Sola S., Brito M.A., Brondino C.D., Brites D., and Moura J.J. Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. Biochem. Biophys. Res. Commun. 281 (2001) 468-474
44. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280 (2005) 17294-17300